Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. - Wikidata - awgldk - TriplyDB

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

http://www.wikidata.org/entity/Q33640054

about

Inflammatory and oxidative stress in rotavirus infection The pharmacological management of severe influenza infection - 'existing and emerging therapies'.Adjunctive therapies and immunomodulating agents for severe influenza.Newer influenza antivirals, biotherapeutics and combinations.Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2.Animal models for influenza viruses: implications for universal vaccine development How to approach and treat viral infections in ICU patients Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis.TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.Into the eye of the cytokine storm.Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.The cytokine storm of severe influenza and development of immunomodulatory therapy Regulation of inducible heme oxygenase and cyclooxygenase isozymes in a mouse model of spotted fever group rickettsiosis.Immunomodulatory therapy for severe influenza.Targeting the "cytokine storm" for therapeutic benefit.The amazing innate immune response to influenza A virus infection.Targeting eicosanoid pathways in the development of novel anti-influenza drugs.Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β pathway.Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Feline calicivirus- and murine norovirus-induced COX-2/PGE2 signaling pathway has proviral effects Treating Influenza Infection, From Now and Into the Future Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy

P2860

Q26749801-248CACF5-D44D-4B5A-AE06-878962338E45 Q30243907-2155C02F-0FE0-4068-861A-E291734447C2 Q30355446-1586D006-8CA1-4E4C-8383-C4DA5B4CEEAE Q30456363-BD9AC2A8-870D-4108-9BF5-CF6F1BB986AA Q34058507-0176868B-14B8-4F32-9022-0AD5E6AB4ACE Q34809686-E8F50380-FC10-48DA-B990-42CB17BDA0CB Q34894660-AF224E48-B24D-4ECE-A3D5-06AC1F3C51CD Q35023278-FBE7A75A-7A49-4B22-9AAB-E69090C8BEB8 Q35672021-B9A8D2C3-E95B-4D7E-9F88-ACC38D14056C Q35804633-FFAB2D44-047F-4D81-A27E-00AA52C04ED8 Q35994233-60CF930B-4C6B-428F-A7CD-17D12458E2BF Q36459143-9D9AA609-8A69-4A14-9C57-DD01C8B5D6AF Q37581961-CDBDE086-222C-412E-AF96-08D517D36E36 Q37910249-8A6BD2EB-0B1B-499B-9A10-DDC05F3E6784 Q38071254-4CBF8D50-9EDB-4D87-8FD5-C709AAB6DDC0 Q38161762-05BFB23C-A6C1-42C1-8159-2025074ABBE9 Q38255645-020ED84A-CC00-4924-BB2E-315E2AB65EF8 Q38330284-75D72ACE-2C8C-4CFE-9E08-0084F85C2EA9 Q39707624-6AB11A15-E46B-455F-8245-A4B603573B41 Q47554935-C8E95B6F-4833-44F2-9F6C-38517E08E040 Q56396401-3127A846-E8D3-4500-8FBE-6236538BDC17 Q57158941-A1B75AB7-9755-448A-AA4B-549495465862 Q58699144-5D858411-5159-44FF-BA8B-F5139A125547

P2860

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

http://www.wikidata.org/entity/Q33640054

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@ast

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@en

type

label

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@ast

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@en

prefLabel

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@ast

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

@en

P1433

Q33640054-5649F426-1EB9-4940-ABAE-AD2E124B334F

P1476

Q33640054-7B152694-D020-4CC4-BA37-E327EC6BB085

P2093

Q33640054-034E70D1-06E7-4E6C-A967-275755EA8122

Q33640054-13313313-08DE-427A-BBEC-1EB505F36B6F

Q33640054-41EB41E2-02D0-4E5F-92BA-7E8FC54144D1

Q33640054-BA8F5E57-715E-45EB-8050-F07D941595A7

Q33640054-C57D3D01-F9D6-4DE8-B08D-C4FCC6715188

P2860

Q33640054-04F80954-96FA-411B-AA53-6EB85EF8EC4D

Q33640054-0FD6E0BD-7E11-4558-A20D-A52F13F99301

Q33640054-1276B964-9A94-4992-B593-13A0583E5D61

Q33640054-1948B8A8-48D1-472D-A807-E318DC9F432A

Q33640054-2EB84D51-36D2-4F02-8C5E-D6939D8B10C0

Q33640054-32262BB8-8418-4A4B-8194-F306A809F2FD

Q33640054-343F1786-0883-4774-9949-226EB4920B20

Q33640054-3967604B-2212-4879-8152-85604FBC99A1

Q33640054-3C076BFF-C8DA-4342-A377-DE12283EA920

Q33640054-3C8EC9DF-51F2-4DA1-BEBA-454753FA71CB

P304

Q33640054-2DB97E9F-870E-44A5-AD9E-91A8C6A8C9A3

P31

Q33640054-FBF143F7-028E-47F6-B7DF-62281081803A

P356

Q33640054-C544D6A8-E5D5-49D7-8A4B-345B357BABA2

P407

Q33640054-4746AFA9-F80B-4F06-AD03-331FC238019B

P433

Q33640054-ED083DB3-02FA-4650-84D6-92B7D8FD26A6

P478

Q33640054-38615403-A4B2-4C5B-8C86-F74CF71A6C23

P50

Q33640054-FE0B95AE-E1C7-4714-997B-BB9A2AB72374

P577

Q33640054-B54A836F-429F-4154-9B0F-7E6A50A0B044

P5875

Q33640054-3A7CAD96-26C6-4320-A29E-A68B47A03546

P698

Q33640054-00482558-6A79-40FB-8F75-D8DF9AA9ADBF

P932

Q33640054-42DB9020-8AB4-4F4B-87C4-9D5B189D90FD

P356

JOURNAL.PONE.0011610

P1433

P1476

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice

@en

P2093

Dori R Germolec

http://www.w3.org/2001/XMLSchema#string

J Alyce Bradbury

http://www.w3.org/2001/XMLSchema#string

Joan P Graves

http://www.w3.org/2001/XMLSchema#string

Michelle A Carey

http://www.w3.org/2001/XMLSchema#string

Yvette D Rebolloso

http://www.w3.org/2001/XMLSchema#string

P2860

Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

P304

e11610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0011610

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Darryl C Zeldin

P577

2010-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45288538

http://www.w3.org/2001/XMLSchema#string

P698

20657653

http://www.w3.org/2001/XMLSchema#string

P932

2904706

http://www.w3.org/2001/XMLSchema#string